购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibiotic
    (1)
  • Apoptosis
    (1)
  • Endogenous Metabolite
    (1)
  • IL Receptor
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (4)
  • 5日内发货
    (3)
  • 6-8周
    (2)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "cervical carcinoma cells"的结果
筛选
搜索结果
TargetMol产品目录中 "

cervical carcinoma cells

"的结果
  • 抑制剂&激动剂
    11
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    3
    TargetMol | Recombinant_Protein
  • 抗体抑制剂
    1
    TargetMol | Inhibitory_Antibodies
  • 天然产物
    8
    TargetMol | Natural_Products
  • β-Aminopropionitrile
    BAPN, 3-氨基丙腈, 3-Aminopropionitrile
    T13475151-18-8
    β-Aminopropionitrile (3-Aminopropionitrile) 是赖氨酰氧化酶的特异性抑制剂。
    • ¥ 157
    In stock
    规格
    数量
  • Ganoderic acid D
    灵芝酸D, 灵芝酸 D
    T5S1133108340-60-9
    Ganoderic acid D 是高度氧化的四环三萜,是灵芝的主要活性成分,可诱导 HeLa 人宫颈癌细胞凋亡。它上调 SIRT3的蛋白质表达并通过 SIRT3 诱导脱乙酰化的亲环蛋白 D 。它抑制结肠癌细胞的能量重编程,包括结肠癌细胞中的葡萄糖摄取,乳酸、丙酮酸和乙酰辅酶的产生。
    • ¥ 649
    In stock
    规格
    数量
  • Ganoderic acid F
    灵芝酸F
    T1136398665-15-7
    Ganoderic acid F 是一种灵芝酸。它具有抗肿瘤和抗转移的活性,与抑制血管生成和涉及细胞增殖和细胞死亡,致癌作用,氧化应激,钙信号传导和内质网应激的蛋白质改变等机制相关。
    • ¥ 993
    In stock
    规格
    数量
  • b-raf in 7
    T609332477725-07-6
    B-Raf IN 7 (compound 6a) 是 B-Raf 的有效抑制剂,IC50值为 110.23 nM。B-Raf IN 7 对结肠癌细胞(HCT-116)、乳腺癌细胞 (MCF-7)、肝癌细胞 (HEPG-2)、人宫颈癌细胞 (Hela) 和人前列腺癌细胞 (PC-3) 具有抗肿瘤活性。其 IC50值分别为 7.50、9.87、10.57、11.63 和 12.83 μM。
    • ¥ 10600
    6-8周
    规格
    数量
  • BPR1K653
    T712791192754-07-6
    BPR1K653 is a potent Aurora kinase inhibitor with potential anticancder activity. BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats., BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.
    • ¥ 10600
    6-8周
    规格
    数量
  • Lirilumab
    利瑞鲁单抗, ONO-4483, IPH2102
    T774231000676-41-4
    Lirilumab (IPH2102) 是一种针对杀伤性免疫球蛋白样受体抗体 KIR2D 的抗体,具有抗肿瘤活性,通过 Vav1 依赖性 NF-κB 去抑制增强自然杀伤细胞的抗 HPV+ 宫颈癌活性,可用于研究白血病、头颈部鳞状细胞癌 (SCCHN)。
    • ¥ 2320
    In stock
    规格
    数量
  • Ganoderic acid S1
    TMA1008104759-35-5
    A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the treatment or prophylaxis of colon ca
    • ¥ 3940
    待询
    规格
    数量
  • Ganoderic acid AM1
    TN4102149507-55-1
    Ganoderic acid AM1 treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.8+ -0.7 microM.
    • ¥ 4560
    待询
    规格
    数量
  • Heliangin
    TN419413323-48-3
    Heliangin shows anti-inflammatory effects, it can inhibit lipopolysaccharide-induced inflammation through signaling NF-κB pathway on LPS-induced RAW 264.7 cells. Heliangin has anti-cancer activity, it exhibits cytotoxicity against human oral epidermoid (
    • ¥ 3710
    待询
    规格
    数量
  • Albiducin A
    TN90702222286-14-6
    Albiducin A 是一种在 Hymenoscyphus albidus 中发现的抗生素,拥有抗菌和抗癌特性。其对细菌和真菌的 MIC 范围为 16.7-66.7 mg mL;对小鼠成纤维细胞系 (Mouse fibroblasts L929) 和人宫颈癌细胞系 (Human cervical carcinoma cell line KB3-1) 的 IC50 分别为 6.1 和 2.7 μg mL。Albiducin A 有潜力在感染和癌症相关研究中发挥作用。
    • 待询
    规格
    数量
  • Nocapyrone Q
    TN91631558013-79-8
    Nocapyrone Q 是一种聚酮类化合物,来源于喀斯特洞穴真菌Streptomyces sp. FD-2-6。该化合物在 100 μM 剂量下,对人肝细胞癌 HepG2 细胞和人宫颈癌 HeLa 细胞表现出抑制活性。Nocapyrone Q 有潜力用于抗癌研究。
    • 待询
    规格
    数量
没有更多数据了